TITLE

Stopping anticoagulant therapy after an unprovoked venous thromboembolism

AUTHOR(S)
Kearon, Clive
PUB. DATE
August 2008
SOURCE
CMAJ: Canadian Medical Association Journal;8/26/2008, Vol. 179 Issue 5, p401
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
The author comments on a study by M. A. Rodger and colleagues about discontinuing anticoagulant therapy after an unprovoked venous thromboembolism. In the study, younger, nonobese women with a history of venous thromboembolism but with no signs of post-thrombotic syndrome, do not need indefinite anticoagulant therapy. The author mentions that the lower risk of recurrent venous thromboembolism in women has previously been observed.
ACCESSION #
33923039

 

Related Articles

  • 6 or 3 months of anticoagulant therapy did not differ for treatment failure in patients with DVT, PE, or both.  // Evidence Based Medicine;Oct2007, Vol. 12 Issue 5, p143 

    The article presents the author's view on the study "Anticoagulation for three versus six months in patients with deep thrombosis or pulmonary embolism, or both: randomized trial." He remarks that the study suggests a comparable efficacy with 3- and 6-moths of anticoagulant therapy, as both...

  • Duration of anticoagulant therapy for deep-vein thrombosis. Farquhar, Donald // CMAJ: Canadian Medical Association Journal;9/4/2001, Vol. 165 Issue 5, p636 

    Presents a clinical update on a study of the duration of anticoagulant therapy for deep-vein thrombosis. Background; Study design; Results; Commentary; Practice implication that physicians must still weigh the risk of recurrent thromboembolism against the risk of significant bleeding.

  • Clinical overview of venous thromboembolism. Schellack, Gustav; Modau, Tumelo; Schellack, Natalie // South African Pharmaceutical Journal;2015, Vol. 82 Issue 10, p21 

    Venous thromboembolism (VTE) encompasses two vascular conditions that are of significant importance, namely deep vein thrombosis (DVT) and pulmonary embolism (PE). DVT is also the most common cause of PE. Medical and surgical patients, and individuals who are at increased risk of developing VTE...

  • Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy. Rodger, Marc A.; Kahn, Susan R.; Wells, Philip S.; Anderson, David A.; Chagnon, Isabelle; Le Gal, Grégoire; Solymoss, Susan; Crowther, Mark; Perrier, Arnaud; White, Richard; Vickars, Linda; Ramsay, Tim; Betancourt, Marisol T.; Kovacs, Michael J. // CMAJ: Canadian Medical Association Journal;8/26/2008, Vol. 179 Issue 5, p417 

    Background: Whether to continue oral anticoagulant therapy beyond 6 months after an "unprovoked" venous thromboembolism is controversial. We sought to determine clinical predictors to identify patients who are at low risk of recurrent venous thromboembolism who could safely discontinue oral...

  • Preventing VTE. CLARK, CHERYL // HealthLeaders Magazine;Nov2012, Vol. 15 Issue 11, p61 

    The article reports on how U.S. healthcare leaders are finding the importance of simple techniques in reducing the incidence of venous thromboembolism (VTE). The status of hospital-associated VTE as a preventable public health problem during and within 90 days of acute care is noted. The...

  • Novel anticoagulants in prevention and treatment of venous thromboembolism. Cosmi, Benilde // Hot Topics in Cardiology;2012, Vol. 7 Issue 29, p13 

    Venous thromboembolism (VTE) encompassing deep vein thrombosis and its potentially fatal complication, pulmonary embolism, are frequent conditions and the third cause of cardiovascular death. The limitations of available anticoagulants for VTE prevention and treatment have spurred the search for...

  • Inherited thrombophilia and pregnancy associated venous thromboembolism. Lim, Wendy; Eikelboom, John W.; Ginsberg, Jeffrey S. // BMJ: British Medical Journal (International Edition);6/23/2007, Vol. 334 Issue 7607, p1318 

    The article presents an overview of inherited thrombophilia and pregnancy associated with thromboembolism. A discussion of the frequency of thromboembolic complications among pregnant women and risk factors for developing thromboembolism during pregnancy is presented. Common symptoms, including...

  • Time to Cardioversion for Acute Atrial Fibrillation and Thromboembolic Complications. Nuotio, Ilpo; Hartikainen, Juha E. K.; Grönberg, Toni; Biancari, Fausto; Juhani Airaksinen, K. E. // JAMA: Journal of the American Medical Association;8/13/2014, Vol. 312 Issue 6, p647 

    The article discusses the link between thromboembolic complications and the use of atrial fibrillation for cardioversion without anticoagulation in less than 49 hours. Topics mentioned include the definition of a thromboembolic event, details of a trial conducted on patients with a primary...

  • Anticoagulant drugs in the elderly: valuable in selected patients. Lowe, G.D.O. // BMJ: British Medical Journal (International Edition);11/12/88, Vol. 297 Issue 6658, p1260 

    Examines the efficacy of anticoagulant drugs for the treatment of venous and arterial thromboembolism. Cause of the death; Occurrence of physical disabilities in the second half of life; Increase of the clotting factor concentration during old age.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics